{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:14:45Z","timestamp":1792826085791,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-05182-z","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:00:39Z","timestamp":1751436039000},"page":"13858-13877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathway Analysis and Genetic Markers in Parkinson\u2019s Disease: Insights into Subtype-Specific Mechanisms"],"prefix":"10.1007","volume":"62","author":[{"given":"Sara Taremi","family":"Horoufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Zaeifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"5182_CR1","doi-asserted-by":"crossref","unstructured":"Kouli A, Torsney KM, Kuan W-L (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. Exon Publications 3\u201326","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"issue":"6","key":"5182_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","volume":"30","author":"CM Lill","year":"2016","unstructured":"Lill CM (2016) Genetics of Parkinson\u2019s disease. Mol Cell Probes 30(6):386\u2013396","journal-title":"Mol Cell Probes"},{"key":"5182_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","volume":"10","author":"N Ball","year":"2019","unstructured":"Ball N, Teo WP, Chandra S, Chapman J (2019) Parkinson\u2019s disease and the environment. Front Neurol 10:218. https:\/\/doi.org\/10.3389\/fneur.2019.00218","journal-title":"Front Neurol"},{"issue":"22","key":"5182_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1212\/01.wnl.0000271880.27321.a7","volume":"69","author":"C Klein","year":"2007","unstructured":"Klein C, Schlossmacher MG (2007) Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder. Neurology 69(22):2093\u20132104. https:\/\/doi.org\/10.1212\/01.wnl.0000271880.27321.a7","journal-title":"Neurology"},{"issue":"12","key":"5182_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18(12):1091\u20131102. https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5","journal-title":"Lancet Neurol"},{"issue":"9","key":"5182_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jocn.2013.12.016","volume":"21","author":"M Lubomski","year":"2014","unstructured":"Lubomski M, Rushworth RL, Lee W, Bertram KL, Williams DR (2014) Sex differences in Parkinson\u2019s disease. J Clin Neurosci 21(9):1503\u20131506","journal-title":"J Clin Neurosci"},{"issue":"2","key":"5182_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/mds.29676","volume":"39","author":"SV Andrews","year":"2024","unstructured":"Andrews SV, Kukkle PL, Menon R, Geetha TS, Goyal V, Kandadai RM, Kumar H, Borgohain R et al (2024) The genetic drivers of juvenile, young, and early-onset Parkinson\u2019s disease in India. Mov Disord 39(2):339\u2013349. https:\/\/doi.org\/10.1002\/mds.29676","journal-title":"Mov Disord"},{"key":"5182_CR8","doi-asserted-by":"crossref","unstructured":"Teeple E, Jindal K, Kiragasi B, Annaldasula S, Byrne A, Chai L, Sadeghi M, Kayatekin C et al (2020) Network analysis and human single cell brain transcriptomics reveal novel aspects of alpha-synuclein (SNCA) biology. bioRxiv","DOI":"10.1101\/2020.06.05.137166"},{"issue":"4","key":"5182_CR9","doi-asserted-by":"publisher","first-page":"fcac165","DOI":"10.1093\/braincomms\/fcac165","volume":"4","author":"AS Kulkarni","year":"2022","unstructured":"Kulkarni AS, Burns MR, Brundin P, Wesson DW (2022) Linking alpha-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson\u2019s disease. Brain Commun 4(4):fcac165. https:\/\/doi.org\/10.1093\/braincomms\/fcac165","journal-title":"Brain Commun"},{"issue":"12","key":"5182_CR10","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1093\/brain\/awad246","volume":"146","author":"AR Hicks","year":"2023","unstructured":"Hicks AR, Reynolds RH, O\u2019Callaghan B, Garcia-Ruiz S, Gil-Martinez AL, Botia J, Plun-Favreau H, Ryten M (2023) The non-specific lethal complex regulates genes and pathways genetically linked to Parkinson\u2019s disease. Brain 146(12):4974\u20134987. https:\/\/doi.org\/10.1093\/brain\/awad246","journal-title":"Brain"},{"key":"5182_CR11","doi-asserted-by":"publisher","first-page":"945574","DOI":"10.3389\/fnins.2022.945574","volume":"16","author":"A Emmi","year":"2022","unstructured":"Emmi A, Antonini A, Sandre M, Baldo A, Contran M, Macchi V, Guidolin D, Porzionato A et al (2022) Topography and distribution of adenosine A(2A) and dopamine D(2) receptors in the human subthalamic nucleus. Front Neurosci 16:945574. https:\/\/doi.org\/10.3389\/fnins.2022.945574","journal-title":"Front Neurosci"},{"issue":"D1","key":"5182_CR12","doi-asserted-by":"publisher","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","volume":"45","author":"The UniProt C","year":"2017","unstructured":"The UniProt C (2017) UniProt: the universal protein knowledgebase. Nucleic Acids Res 45(D1):D158\u2013D169. https:\/\/doi.org\/10.1093\/nar\/gkw1099","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5182_CR13","doi-asserted-by":"publisher","first-page":"D835","DOI":"10.1093\/nar\/gkz972","volume":"48","author":"MJ Landrum","year":"2020","unstructured":"Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, Hoffman D, Jang W et al (2020) ClinVar: improvements to accessing data. Nucleic Acids Res 48(D1):D835\u2013D844. https:\/\/doi.org\/10.1093\/nar\/gkz972","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5182_CR14","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkz895","volume":"48","author":"T Beck","year":"2020","unstructured":"Beck T, Shorter T, Brookes AJ (2020) GWAS Central: a comprehensive resource for the discovery and comparison of genotype and phenotype data from genome-wide association studies. Nucleic Acids Res 48(D1):D933\u2013D940. https:\/\/doi.org\/10.1093\/nar\/gkz895","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"5182_CR15","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ (2021) Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res 49(D1):D1138\u2013D1143. https:\/\/doi.org\/10.1093\/nar\/gkaa891","journal-title":"Nucleic Acids Res"},{"key":"5182_CR16","volume-title":"Orphanet: an online database of rare diseases and orphan drugs","author":"INSERM","year":"1997","unstructured":"INSERM (1997) Orphanet: an online database of rare diseases and orphan drugs. INSERM, Copyright"},{"issue":"8","key":"5182_CR17","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/humu.24291","volume":"43","author":"C Thaxton","year":"2022","unstructured":"Thaxton C, Good ME, DiStefano MT, Luo X, Andersen EF, Thorland E, Berg J, Martin CL et al (2022) Utilizing ClinGen gene-disease validity and dosage sensitivity curations to inform variant classification. Hum Mutat 43(8):1031\u20131040. https:\/\/doi.org\/10.1002\/humu.24291","journal-title":"Hum Mutat"},{"issue":"3","key":"5182_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/0963662517747200","volume":"27","author":"GN Samuel","year":"2018","unstructured":"Samuel GN, Farsides B (2018) Genomics England\u2019s implementation of its public engagement strategy: blurred boundaries between engagement for the United Kingdom\u2019s 100,000 Genomes project and the need for public support. Public Underst Sci 27(3):352\u2013364. https:\/\/doi.org\/10.1177\/0963662517747200","journal-title":"Public Underst Sci"},{"issue":"1","key":"5182_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13073-018-0531-8","volume":"10","author":"D Tamborero","year":"2018","unstructured":"Tamborero D, Rubio-Perez C, Deu-Pons J, Schroeder MP, Vivancos A, Rovira A, Tusquets I, Albanell J et al (2018) Cancer genome interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med 10(1):25. https:\/\/doi.org\/10.1186\/s13073-018-0531-8","journal-title":"Genome Med"},{"issue":"24","key":"5182_CR20","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1093\/bioinformatics\/btx506","volume":"33","author":"A Gutierrez-Sacristan","year":"2017","unstructured":"Gutierrez-Sacristan A, Hernandez-Ferrer C, Gonzalez JR, Furlong LI (2017) psygenet2r: a R\/Bioconductor package for the analysis of psychiatric disease genes. Bioinformatics 33(24):4004\u20134006. https:\/\/doi.org\/10.1093\/bioinformatics\/btx506","journal-title":"Bioinformatics"},{"key":"5182_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2105-9-207","volume":"9","author":"M Bundschus","year":"2008","unstructured":"Bundschus M, Dejori M, Stetter M, Tresp V, Kriegel HP (2008) Extraction of semantic biomedical relations from text using conditional random fields. BMC Bioinformatics 9:207. https:\/\/doi.org\/10.1186\/1471-2105-9-207","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"5182_CR22","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward M-H, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1):308\u2013311","journal-title":"Nucleic Acids Res"},{"issue":"s1","key":"5182_CR23","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.3233\/JPD-202135","volume":"10","author":"B Post","year":"2020","unstructured":"Post B, van den Heuvel L, van Prooije T, van Ruissen X, van de Warrenburg B, Nonnekes J (2020) Young onset Parkinson\u2019s disease: a modern and tailored approach. J Parkinsons Dis 10(s1):S29\u2013S36. https:\/\/doi.org\/10.3233\/JPD-202135","journal-title":"J Parkinsons Dis"},{"issue":"W1","key":"5182_CR24","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","volume":"51","author":"L Kolberg","year":"2023","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Adler P, Vilo J, Peterson H (2023) g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res 51(W1):W207\u2013W212. https:\/\/doi.org\/10.1093\/nar\/gkad347","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5182_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H","volume":"17","author":"J Wixon","year":"2000","unstructured":"Wixon J, Kell D (2000) The Kyoto encyclopedia of genes and genomes\u2013KEGG. Yeast 17(1):48\u201355. https:\/\/doi.org\/10.1002\/(SICI)1097-0061(200004)17:1%3c48::AID-YEA2%3e3.0.CO;2-H","journal-title":"Yeast"},{"issue":"D1","key":"5182_CR26","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"5182_CR27","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"issue":"7","key":"5182_CR28","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/nar\/30.7.1575","volume":"30","author":"AJ Enright","year":"2002","unstructured":"Enright AJ, Van Dongen S, Ouzounis CA (2002) An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 30(7):1575\u20131584. https:\/\/doi.org\/10.1093\/nar\/30.7.1575","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"5182_CR29","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(Suppl 4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11","journal-title":"BMC Syst Biol"},{"key":"5182_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.12688\/f1000research.4477.2","volume":"3","author":"G Scardoni","year":"2014","unstructured":"Scardoni G, Tosadori G, Faizan M, Spoto F, Fabbri F, Laudanna C (2014) Biological network analysis with CentiScaPe: centralities and experimental dataset integration. F1000Res 3:139. https:\/\/doi.org\/10.12688\/f1000research.4477.2","journal-title":"F1000Res"},{"issue":"W1","key":"5182_CR31","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan AB, Torre D, Lachmann A, Leong AK, Wojciechowicz ML, Utti V, Jagodnik KM, Kropiwnicki E et al (2019) ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res 47(W1):W212\u2013W224. https:\/\/doi.org\/10.1093\/nar\/gkz446","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5182_CR32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12859-019-3105-x","volume":"20","author":"V Licursi","year":"2019","unstructured":"Licursi V, Conte F, Fiscon G, Paci P (2019) MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinformatics 20(1):545. https:\/\/doi.org\/10.1186\/s12859-019-3105-x","journal-title":"BMC Bioinformatics"},{"key":"5182_CR33","doi-asserted-by":"publisher","unstructured":"Kim JJ, Vitale D, Otani DV, Lian MM, Heilbron K, Me Research T, Iwaki H, Lake J et al (2024) Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat Genet 56 (1):27-36. https:\/\/doi.org\/10.1038\/s41588-023-01584-8","DOI":"10.1038\/s41588-023-01584-8"},{"issue":"6","key":"5182_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM De Lau","year":"2006","unstructured":"De Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. The Lancet Neurology 5(6):525\u2013535","journal-title":"The Lancet Neurology"},{"issue":"3","key":"5182_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.osfp.2013.01.003","volume":"5","author":"SC Yao","year":"2013","unstructured":"Yao SC, Hart AD, Terzella MJ (2013) An evidence-based osteopathic approach to Parkinson disease. Osteopathic Fam Phys 5(3):96\u2013101","journal-title":"Osteopathic Fam Phys"},{"key":"5182_CR36","doi-asserted-by":"publisher","unstructured":"Calvano CD, Losito I, Cataldi T (2021) Editorial to the special issue \u201clipidomics and neurodegenerative diseases\u201d. Int J Mol Sci 22 (3). https:\/\/doi.org\/10.3390\/ijms22031270","DOI":"10.3390\/ijms22031270"},{"key":"5182_CR37","doi-asserted-by":"publisher","unstructured":"Fais M, Dore A, Galioto M, Galleri G, Crosio C, Iaccarino C (2021) Parkinson\u2019s disease-related genes and lipid alteration. Int J Mol Sci 22 (14). https:\/\/doi.org\/10.3390\/ijms22147630","DOI":"10.3390\/ijms22147630"},{"issue":"10","key":"5182_CR38","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","volume":"145","author":"J Galper","year":"2022","unstructured":"Galper J, Dean NJ, Pickford R, Lewis SJG, Halliday GM, Kim WS, Dzamko N (2022) Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease. Brain 145(10):3472\u20133487. https:\/\/doi.org\/10.1093\/brain\/awac176","journal-title":"Brain"},{"key":"5182_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnmol.2020.00080","volume":"13","author":"L Hu","year":"2020","unstructured":"Hu L, Dong MX, Huang YL, Lu CQ, Qian Q, Zhang CC, Xu XM, Liu Y et al (2020) Integrated metabolomics and proteomics analysis reveals plasma lipid metabolic disturbance in patients with Parkinson\u2019s disease. Front Mol Neurosci 13:80. https:\/\/doi.org\/10.3389\/fnmol.2020.00080","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"5182_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41531-023-00459-3","volume":"9","author":"J Jacquemyn","year":"2023","unstructured":"Jacquemyn J, Kuenen S, Swerts J, Pavie B, Vijayan V, Kilic A, Chabot D, Wang YC et al (2023) Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1. NPJ Parkinsons Dis 9(1):19. https:\/\/doi.org\/10.1038\/s41531-023-00459-3","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"5182_CR41","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1212\/NXG.0000000000000620","volume":"7","author":"W Vandenberghe","year":"2021","unstructured":"Vandenberghe W, Imberechts D, Van Laere K, Jannis L, De Hertogh G, Ronisz A, Thal DR (2021) Tau pathology associated with Parkinsonism and mutation of mitochondrial DNA helicase gene TWNK. Neurol Genet 7(5):e620. https:\/\/doi.org\/10.1212\/NXG.0000000000000620","journal-title":"Neurol Genet"},{"issue":"6","key":"5182_CR42","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/acn3.51781","volume":"10","author":"Y Bakhit","year":"2023","unstructured":"Bakhit Y, Tesson C, Ibrahim MO, Eltom K, Eltazi I, Elsayed LEO, Lesage S, Seidi O et al (2023) PLA2G6-associated late-onset parkinsonism in a Sudanese family. Ann Clin Transl Neurol 10(6):983\u2013989. https:\/\/doi.org\/10.1002\/acn3.51781","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"5182_CR43","doi-asserted-by":"publisher","first-page":"e14387","DOI":"10.1111\/cns.14387","volume":"30","author":"J Ren","year":"2024","unstructured":"Ren J, Zhan X, Zhou H, Guo Z, Xing Y, Yin H, Xue C, Wu J et al (2024) Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson\u2019s disease. CNS Neurosci Ther 30(2):e14387. https:\/\/doi.org\/10.1111\/cns.14387","journal-title":"CNS Neurosci Ther"},{"key":"5182_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fnins.2020.00353","volume":"14","author":"X Wang","year":"2020","unstructured":"Wang X, Sun X, Niu M, Zhang X, Wang J, Zhou C, Xie A (2020) RAGE silencing ameliorates neuroinflammation by inhibition of p38-NF-kappaB signaling pathway in mouse model of Parkinson\u2019s disease. Front Neurosci 14:353. https:\/\/doi.org\/10.3389\/fnins.2020.00353","journal-title":"Front Neurosci"},{"key":"5182_CR45","doi-asserted-by":"publisher","first-page":"747387","DOI":"10.3389\/fimmu.2021.747387","volume":"12","author":"A Llibre","year":"2021","unstructured":"Llibre A, Dedicoat M, Burel JG, Demangel C, O\u2019Shea MK, Mauro C (2021) Host immune-metabolic adaptations upon mycobacterial infections and associated co-morbidities. Front Immunol 12:747387. https:\/\/doi.org\/10.3389\/fimmu.2021.747387","journal-title":"Front Immunol"},{"issue":"2","key":"5182_CR46","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/1673-5374.317981","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yuan M, Liu Y, Yang F, Chen WZ, Xu ZZ, Xiang ZB, Xu RS (2022) Association between inflammatory bowel diseases and Parkinson\u2019s disease: systematic review and meta-analysis. Neural Regen Res 17(2):344\u2013353. https:\/\/doi.org\/10.4103\/1673-5374.317981","journal-title":"Neural Regen Res"},{"issue":"12","key":"5182_CR47","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1002\/mds.29610","volume":"38","author":"K Daida","year":"2023","unstructured":"Daida K, Funayama M, Billingsley KJ, Malik L, Miano-Burkhardt A, Leonard HL, Makarious MB, Iwaki H et al (2023) Long-read sequencing resolves a complex structural variant in PRKN Parkinson\u2019s disease. Mov Disord 38(12):2249\u20132257. https:\/\/doi.org\/10.1002\/mds.29610","journal-title":"Mov Disord"},{"issue":"3","key":"5182_CR48","doi-asserted-by":"publisher","first-page":"fcab197","DOI":"10.1093\/braincomms\/fcab197","volume":"3","author":"H Mor-Shaked","year":"2021","unstructured":"Mor-Shaked H, Paz-Ebstein E, Basal A, Ben-Haim S, Grobe H, Heymann S, Israel Z, Namnah M et al (2021) Levodopa-responsive dystonia caused by biallelic PRKN exon inversion invisible to exome sequencing. Brain Commun 3(3):fcab197. https:\/\/doi.org\/10.1093\/braincomms\/fcab197","journal-title":"Brain Commun"},{"issue":"10","key":"5182_CR49","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/mdc3.13852","volume":"10","author":"RN Duan","year":"2023","unstructured":"Duan RN, Liu GY, Han YL, Li PZ, Zhang BH, Liu YM (2023) Characterization of SNCA multiplication in Parkinson\u2019s disease: 2 new cases and evaluation of the literature. Mov Disord Clin Pract 10(10):1536\u20131541. https:\/\/doi.org\/10.1002\/mdc3.13852","journal-title":"Mov Disord Clin Pract"},{"issue":"6","key":"5182_CR50","doi-asserted-by":"publisher","first-page":"eadj4767","DOI":"10.1126\/sciadv.adj4767","volume":"10","author":"S Santhosh Kumar","year":"2024","unstructured":"Santhosh Kumar S, Naseri NN, Pather SR, Hallacli E, Ndayisaba A, Buenaventura C, Acosta K, Roof J et al (2024) Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Sci Adv 10(6):eadj4767. https:\/\/doi.org\/10.1126\/sciadv.adj4767","journal-title":"Sci Adv"},{"issue":"1","key":"5182_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41531-022-00379-8","volume":"8","author":"I Wurster","year":"2022","unstructured":"Wurster I, Quadalti C, Rossi M, Hauser AK, Deuschle C, Schulte C, Waniek K, Lachmann I et al (2022) Linking the phenotype of SNCA triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding. NPJ Parkinsons Dis 8(1):117. https:\/\/doi.org\/10.1038\/s41531-022-00379-8","journal-title":"NPJ Parkinsons Dis"},{"key":"5182_CR52","doi-asserted-by":"publisher","first-page":"889802","DOI":"10.3389\/fnins.2022.889802","volume":"16","author":"J Prahl","year":"2022","unstructured":"Prahl J, Coetzee GA (2022) Genetic elements at the alpha-synuclein locus. Front Neurosci 16:889802. https:\/\/doi.org\/10.3389\/fnins.2022.889802","journal-title":"Front Neurosci"},{"issue":"5","key":"5182_CR53","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/brain\/awab073","volume":"144","author":"F Pischedda","year":"2021","unstructured":"Pischedda F, Cirnaru MD, Ponzoni L, Sandre M, Biosa A, Carrion MP, Marin O, Morari M et al (2021) LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation. Brain 144(5):1509\u20131525. https:\/\/doi.org\/10.1093\/brain\/awab073","journal-title":"Brain"},{"issue":"43","key":"5182_CR54","doi-asserted-by":"publisher","first-page":"e2205492119","DOI":"10.1073\/pnas.2205492119","volume":"119","author":"JH Kluss","year":"2022","unstructured":"Kluss JH, Beilina A, Williamson CD, Lewis PA, Cookson MR, Bonet-Ponce L (2022) Lysosomal positioning regulates Rab10 phosphorylation at LRRK2(+) lysosomes. Proc Natl Acad Sci U S A 119(43):e2205492119. https:\/\/doi.org\/10.1073\/pnas.2205492119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"5182_CR55","doi-asserted-by":"publisher","first-page":"eadk6191","DOI":"10.1126\/sciadv.adk6191","volume":"9","author":"M Sanz Murillo","year":"2023","unstructured":"Sanz Murillo M, Villagran Suarez A, Dederer V, Chatterjee D, AlegrioLouro J, Knapp S, Mathea S, Leschziner AE (2023) Inhibition of Parkinson\u2019s disease-related LRRK2 by type I and type II kinase inhibitors: activity and structures. Sci Adv 9(48):eadk6191. https:\/\/doi.org\/10.1126\/sciadv.adk6191","journal-title":"Sci Adv"},{"issue":"5","key":"5182_CR56","doi-asserted-by":"publisher","first-page":"e22930","DOI":"10.1096\/fj.202200780RR","volume":"37","author":"K Ito","year":"2023","unstructured":"Ito K, Araki M, Katai Y, Nishimura Y, Imotani S, Inoue H, Ito G, Tomita T (2023) Pathogenic LRRK2 compromises the subcellular distribution of lysosomes in a Rab12-RILPL1-dependent manner. FASEB J 37(5):e22930. https:\/\/doi.org\/10.1096\/fj.202200780RR","journal-title":"FASEB J"},{"key":"5182_CR57","doi-asserted-by":"publisher","unstructured":"Rivero-Rios P, Romo-Lozano M, Fernandez B, Fdez E, Hilfiker S (2020) Distinct roles for RAB10 and RAB29 in pathogenic LRRK2-mediated endolysosomal trafficking alterations. Cells 9 (7). https:\/\/doi.org\/10.3390\/cells9071719","DOI":"10.3390\/cells9071719"},{"issue":"31","key":"5182_CR58","doi-asserted-by":"publisher","first-page":"e2303789120","DOI":"10.1073\/pnas.2303789120","volume":"120","author":"N Yadavalli","year":"2023","unstructured":"Yadavalli N, Ferguson SM (2023) LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition. Proc Natl Acad Sci U S A 120(31):e2303789120. https:\/\/doi.org\/10.1073\/pnas.2303789120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5182_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-020-00218-x","volume":"9","author":"CU von Linstow","year":"2020","unstructured":"von Linstow CU, Gan-Or Z, Brundin P (2020) Precision medicine in Parkinson\u2019s disease patients with LRRK2 and GBA risk variants - let\u2019s get even more personal. Transl Neurodegener 9(1):39. https:\/\/doi.org\/10.1186\/s40035-020-00218-x","journal-title":"Transl Neurodegener"},{"key":"5182_CR60","doi-asserted-by":"publisher","unstructured":"Yi S, Wang L, Wang H, Ho MS, Zhang S (2022) Pathogenesis of alpha-synuclein in Parkinson\u2019s disease: From a Neuron-Glia Crosstalk Perspective. Int J Mol Sci 23 (23). https:\/\/doi.org\/10.3390\/ijms232314753","DOI":"10.3390\/ijms232314753"},{"key":"5182_CR61","doi-asserted-by":"publisher","unstructured":"Nevra A, Arzu A (2019) The relationship between alpha-synuclein (SNCA) gene polymorphisms and development risk of Parkinson\u2019s disease. In: Andrei S (ed) Synucleins. IntechOpen, Rijeka, p Ch. 3. https:\/\/doi.org\/10.5772\/intechopen.82808","DOI":"10.5772\/intechopen.82808"},{"key":"5182_CR62","doi-asserted-by":"publisher","unstructured":"Strafella C, Caputo V, Termine A, Barati S, Caltagirone C, Giardina E, Cascella R (2020) Investigation of genetic variations of IL6 and IL6R as potential prognostic and pharmacogenetics biomarkers: implications for COVID-19 and neuroinflammatory disorders. Life (Basel) 10 (12). https:\/\/doi.org\/10.3390\/life10120351","DOI":"10.3390\/life10120351"},{"issue":"10","key":"5182_CR63","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/brain\/awaa246","volume":"143","author":"M Borsche","year":"2020","unstructured":"Borsche M, Konig IR, Delcambre S, Petrucci S, Balck A, Bruggemann N, Zimprich A, Wasner K et al (2020) Mitochondrial damage-associated inflammation highlights biomarkers in PRKN\/PINK1 parkinsonism. Brain 143(10):3041\u20133051. https:\/\/doi.org\/10.1093\/brain\/awaa246","journal-title":"Brain"},{"issue":"2","key":"5182_CR64","doi-asserted-by":"publisher","first-page":"e12671","DOI":"10.1016\/j.heliyon.2022.e12671","volume":"9","author":"M Gao","year":"2023","unstructured":"Gao M, Zhang C, Gao L, Sun S, Song L, Liu S (2023) Association between C-reactive protein-albumin ratio and overall survival in Parkinson\u2019s disease using publicly available data: a retrospective cohort study. Heliyon 9(2):e12671. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12671","journal-title":"Heliyon"},{"issue":"4","key":"5182_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.37349\/ent.2023.00048","volume":"3","author":"G Henriquez","year":"2023","unstructured":"Henriquez G, Narayan M (2023) Targeting \u03b1-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson\u2019s disease. Exploration Neuroprotective Ther 3(4):207\u2013234. https:\/\/doi.org\/10.37349\/ent.2023.00048","journal-title":"Exploration Neuroprotective Ther"},{"issue":"3","key":"5182_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N (2023) Molecular genetics of Parkinson\u2019s disease: contributions and global trends. J Hum Genet 68(3):125\u2013130. https:\/\/doi.org\/10.1038\/s10038-022-01058-5","journal-title":"J Hum Genet"},{"issue":"6","key":"5182_CR67","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awab456","volume":"145","author":"W Zhu","year":"2022","unstructured":"Zhu W, Huang X, Yoon E, Bandres-Ciga S, Blauwendraat C, Billingsley KJ, Cade JH, Wu BP et al (2022) Heterozygous PRKN mutations are common but do not increase the risk of Parkinson\u2019s disease. Brain 145(6):2077\u20132091. https:\/\/doi.org\/10.1093\/brain\/awab456","journal-title":"Brain"},{"issue":"1","key":"5182_CR68","doi-asserted-by":"publisher","first-page":"18275","DOI":"10.1038\/s41598-020-75104-7","volume":"10","author":"A Brewer","year":"2020","unstructured":"Brewer A, Cormican P, Lim JJ, Chapwanya A, O\u2019Farrelly C, Meade KG (2020) Qualitative and quantitative differences in endometrial inflammatory gene expression precede the development of bovine uterine disease. Sci Rep 10(1):18275. https:\/\/doi.org\/10.1038\/s41598-020-75104-7","journal-title":"Sci Rep"},{"issue":"1","key":"5182_CR69","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1038\/s41598-022-10528-x","volume":"12","author":"K Ihara","year":"2022","unstructured":"Ihara K, Oguro A, Imaishi H (2022) Diagnosis of Parkinson\u2019s disease by investigating the inhibitory effect of serum components on P450 inhibition assay. Sci Rep 12(1):6622. https:\/\/doi.org\/10.1038\/s41598-022-10528-x","journal-title":"Sci Rep"},{"key":"5182_CR70","doi-asserted-by":"publisher","unstructured":"Leston Pinilla L, Ugun-Klusek A, Rutella S, De Girolamo LA (2021) Hypoxia signaling in Parkinson\u2019s disease: there is use in asking \u201cwhat HIF?\u201d. Biology (Basel) 10 (8). https:\/\/doi.org\/10.3390\/biology10080723","DOI":"10.3390\/biology10080723"},{"issue":"18","key":"5182_CR71","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","volume":"80","author":"L Xiao","year":"2020","unstructured":"Xiao L, Li X, Mu Z, Zhou J, Zhou P, Xie C, Jiang S (2020) FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma. Cancer Res 80(18):3945\u20133958. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0132","journal-title":"Cancer Res"},{"key":"5182_CR72","doi-asserted-by":"publisher","first-page":"999236","DOI":"10.3389\/fendo.2022.999236","volume":"13","author":"Z Koszegi","year":"2022","unstructured":"Koszegi Z, Cheong RY (2022) Targeting the non-classical estrogen pathway in neurodegenerative diseases and brain injury disorders. Front Endocrinol (Lausanne) 13:999236. https:\/\/doi.org\/10.3389\/fendo.2022.999236","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5182_CR73","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fnagi.2017.00430","volume":"9","author":"S Zarate","year":"2017","unstructured":"Zarate S, Stevnsner T, Gredilla R (2017) Role of estrogen and other sex hormones in brain aging. Neuroprotection and DNA repair. Front Aging Neurosci 9:430. https:\/\/doi.org\/10.3389\/fnagi.2017.00430","journal-title":"Front Aging Neurosci"},{"key":"5182_CR74","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1471-2407-14-378","volume":"14","author":"L Su","year":"2014","unstructured":"Su L, Liu X, Chai N, Lv L, Wang R, Li X, Nie Y, Shi Y et al (2014) The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer. BMC Cancer 14:378. https:\/\/doi.org\/10.1186\/1471-2407-14-378","journal-title":"BMC Cancer"},{"key":"5182_CR75","doi-asserted-by":"publisher","unstructured":"Zhang Y, Hou L (2021) Alternate roles of Sox transcription factors beyond transcription initiation. Int J Mol Sci 22 (11). https:\/\/doi.org\/10.3390\/ijms22115949","DOI":"10.3390\/ijms22115949"},{"key":"5182_CR76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cellsig.2018.08.009","volume":"51","author":"Z Hu","year":"2018","unstructured":"Hu Z, Wang F, Wu Z, Gu H, Dong N, Jiang X, Xu J, Wu Z et al (2018) FOXO3a-dependent up-regulation of Mxi1-0 promotes hypoxia-induced apoptosis in endothelial cells. Cell Signal 51:233\u2013242. https:\/\/doi.org\/10.1016\/j.cellsig.2018.08.009","journal-title":"Cell Signal"},{"key":"5182_CR77","doi-asserted-by":"publisher","unstructured":"Kamdar RD, Harrington BS, Attar E, Korrapati S, Shetty J, Zhao Y, Tran B, Wong N et al (2023) NF-kappaB signaling modulates miR-452\u20135p and miR-335\u20135p expression to functionally decrease epithelial ovarian cancer progression in tumor-initiating cells. Int J Mol Sci 24 (9). https:\/\/doi.org\/10.3390\/ijms24097826","DOI":"10.3390\/ijms24097826"},{"issue":"5","key":"5182_CR78","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/cbdd.14132","volume":"101","author":"A Mukherjee","year":"2023","unstructured":"Mukherjee A, Acharya PB, Singh A, Kuppusamy Selvam M (2023) Identification of therapeutic miRNAs from the arsenic induced gene expression profile of hepatocellular carcinoma. Chem Biol Drug Des 101(5):1027\u20131041. https:\/\/doi.org\/10.1111\/cbdd.14132","journal-title":"Chem Biol Drug Des"},{"key":"5182_CR79","doi-asserted-by":"publisher","unstructured":"Bougea A (2022) MicroRNA as candidate biomarkers in atypical Parkinsonian syndromes: systematic literature review. Medicina (Kaunas) 58 (4). https:\/\/doi.org\/10.3390\/medicina58040483","DOI":"10.3390\/medicina58040483"},{"issue":"1","key":"5182_CR80","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1038\/s41598-022-08916-4","volume":"12","author":"M Sotoudeh Anvari","year":"2022","unstructured":"Sotoudeh Anvari M, Vasei H, Najmabadi H, Badv RS, Golipour A, Mohammadi-Yeganeh S, Salehi S, Mohamadi M et al (2022) Identification of microRNAs associated with human fragile X syndrome using next-generation sequencing. Sci Rep 12(1):5011. https:\/\/doi.org\/10.1038\/s41598-022-08916-4","journal-title":"Sci Rep"},{"issue":"1","key":"5182_CR81","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41598-022-05227-6","volume":"12","author":"E Zago","year":"2022","unstructured":"Zago E, Dal Molin A, Dimitri GM, Xumerle L, Pirazzini C, Bacalini MG, Maturo MG, Azevedo T et al (2022) Early downregulation of hsa-miR-144-3p in serum from drug-naive Parkinson\u2019s disease patients. Sci Rep 12(1):1330. https:\/\/doi.org\/10.1038\/s41598-022-05227-6","journal-title":"Sci Rep"},{"issue":"7","key":"5182_CR82","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jog.14307","volume":"46","author":"R Wang","year":"2020","unstructured":"Wang R, Lu A, Liu W, Yue J, Sun Q, Chen J, Luan H, Zhai Y et al (2020) Searching for valuable differentially expressed miRNAs in postmenopausal osteoporosis by RNA sequencing. J Obstet Gynaecol Res 46(7):1183\u20131192. https:\/\/doi.org\/10.1111\/jog.14307","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"5182_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/ds.ds_5_21","volume":"39","author":"X Miao","year":"2021","unstructured":"Miao X, Tong X, Hu J, Wang J (2021) Diagnostic value of microRNA-106a-5p in patients with psoriasis and its regulatory role in inflammatory responses. Dermatol Sin 39(2):67\u201373. https:\/\/doi.org\/10.4103\/ds.ds_5_21","journal-title":"Dermatol Sin"},{"issue":"1","key":"5182_CR84","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13287-022-03015-7","volume":"13","author":"ZH Liang","year":"2022","unstructured":"Liang ZH, Pan NF, Lin SS, Qiu ZY, Liang P, Wang J, Zhang Z, Pan YC (2022) Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4\/p38MAPK pathway. Stem Cell Res Ther 13(1):336. https:\/\/doi.org\/10.1186\/s13287-022-03015-7","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"5182_CR85","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2174\/156720507781788873","volume":"4","author":"D Tweedie","year":"2007","unstructured":"Tweedie D, Sambamurti K, Greig NH (2007) TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr Alzheimer Res 4(4):378\u2013385. https:\/\/doi.org\/10.2174\/156720507781788873","journal-title":"Curr Alzheimer Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05182-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05182-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:28:07Z","timestamp":1759994887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05182-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5182"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05182-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}